Noubar Afeyan
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
Noubar Afeyan
May 10, 2024, 15:41 |
Drugs
Noubar Afeyan: Our partnership with Novo Nordisk brings together the best of two companies in drug development
Noubar Afeyan, Founder and CEO of Flagship Pioneering, shared a post by Flagship Pioneering on…
Apr 13, 2024, 12:29 |
Blog
Noubar Afeyan: A Tale of Two Articles...
Noubar Afeyan, Founder and CEO of Flagship Pioneering, shared on LinkedIn: "A Tale of Two…
Mar 26, 2024, 18:49 |
Blog
Noubar Afeyan: The U.S. House of Representatives passed the Preventive Health Savings Act, a significant step towards a true healthcare system
Noubar Afeyan, Founder and CEO of Flagship Pioneering, shared on LinkedIn: "UPDATE: Last night the U.S.…
Jan 12, 2024, 11:08 |
Blog
Noubar Afeyan: An audio version of Flagship’s 2024 Annual Letter
Noubar Afeyan, Founder and CEO of Flagship Pioneering, shared a post by Flagship Pioneering on LinkedIn,…
Nov 24, 2023, 13:53 |
Stories
Noubar Afeyan's story of becoming an entrepreneur
Noubar Afeyan, Founder and CEO of Flagship Pioneering, shared on LinkedIn: "Back in 1985, my…
Nov 10, 2023, 17:29 |
Insight
Noubar Afeyan: We are at a seismic moment for life sciences and biotech technologies
Noubar Afeyan, Founder and CEO of Flagship Pioneering, shared on LinkedIn: "We are at a…
All:
6
Posts:
1 - 10
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Barbara Jereczek-Fossa has been elected as the ESTRO President-elect!
Facebook
RSS Feed
Twitter
Linkedin
Youtube